Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Tinnitus
Clinical narrative: little anxiety; has had ongoing issues with tinnitus and stated he thinks the tinnitus has worsened since the vaccine/has a condition, tinnitus, it seems like its kind of maybe worsened it a little bit/tinnitus; This is a spontaneous report from a contactable consumer (patient). A 62-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/lot number: EW0153, Expiry Date: Unknown), via an unspecified route on 09Apr2021 15:00 (at the age of 62-year-old), administered in left arm/shoulder at 0.3 ml as single dose for COVID-19 immunization administered at Hospital. Medical history included ongoing issues with tinnitus (Diagnosed: 6-8 years ago) and high blood pressure (Diagnosed: 8-10 years). Concomitant medications were reported as none. The patient reported that he did not take any concomitant medications or had done was a change in his life or medications, before or after the injection everything was the same. On an unspecified date, the patient stated he thinks the tinnitus has worsened since the vaccine. Patient stated he was afraid of getting the second shot. The patient had tinnitus after the first dose of the Pfizer COVID-19 vaccine and said he should have had the second dose at the end of April or beginning of May but didn't get it because of the tinnitus. Patient asked have there been any reports of tinnitus. Patient asked if later down the road if they have a booster would it be an option for him or not if he does not take the second vaccine. Has Pfizer provided a statement on the need for a booster dose (3rd dose)? Is Pfizer investigating the need for a booster dose. Patient wanted to know, what percentage of protection does he have with one shot. He has had tinnitus for several years, and says it was not a result of this, and it may be incorrect but he felt like it worsened it a little bit. He says he had a little anxiety and decided not to take the second injection at the time. He says that his question is about the second dose that would have been 30Apr, whether he can go ahead and take the next one as the second vaccine dose or if he needs to have booster instead. Upon follow up on 29Apr2021, the patient reported, No other vaccinations within four weeks prior to the first administration date of the suspect vaccine. The patient reported that he gets a little anxious as he doesn't know if there was a treatment for tinnitus. The outcome of  tinnitus was not resolved and anxiety was unknown.  Follow-up (29Apr2021): New information received from a contactable consumer includes: Age of the patient with units, Lot Number, complete dosage regimen, Vaccination Facility Type (Hospital), Medical history (high blood pressure) and ongoing status, Date of start of reaction/event tinnitus (Apr2021 to ongoing), Outcome of the event (not recovered) updated.  Follow-up (01Sep2021): This is a follow-up spontaneous report from a Pfizer-sponsored program. This 62-year-old male consumer (patient) reported that: Added new event (little anxiety), clinical date updated.  Follow-Up (09Sep2021): Follow-up attempts are completed. No further information is expected.